The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global white biotechnology market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 10% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use industries. These insights are included in the report as a major market contributor.
White biotechnology, or industrial biotechnology, involves the use of biocatalysts, such as enzymes and microorganisms, for developing degradable and bio-based products by implementing the scientific principles of biotechnology in industrial settings. It is commonly used to produce various essential bioactive compounds, secondary metabolites, pigments, organic substances, such as citric acid, acetic acid, glycerin and acetone, and antibiotics, such as penicillin, streptomycin and mitomycin. It is also used for the manufacturing of metabolites, biodegradable plastics, biocontrol agents, bio-based fuel, sustainable energy and waste treatment. As a result, white biotechnology finds extensive applications across various industries, including bioenergy, textile, construction, chemical, food and beverage and pharmaceutical.
The increasing demand for green chemicals and biofuels, such as bioethanol and biodiesel, across the globe, is one of the key factors driving the growth of the market. With the rising environmental consciousness among the masses, consumers are increasingly demanding premium green renewable products for personal and industrial consumption, especially in the developed economies. Moreover, the utilization of bacteria and microalgae for the biosynthesis of nanomaterials and structures, including bacterial nanocellulose, exopolysaccharides and nanowires, is providing a thrust to the market growth. As the coronavirus disease (COVID-19) continues to spread, there has been a significant increase in the demand for natural alcohol for manufacturing skin-friendly hand sanitizers across the globe. Additionally, various innovations, such as the development of bioinspired calcium phosphate cement to glue tissues to metallic and polymeric biomaterials, are also contributing to the market growth. Other factors, including extensive research and development (R&D) activities in the field of biotechnology, along with the implementation of favorable government policies, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global white biotechnology market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product and application.
Breakup by Product:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Archer Daniels Midland Company, BASF SE, Cargill Inc., DuPont de Nemours Inc., Fujifilm Holdings Corporation, General Electric Company, Henkel AG & Co. KGaA, Kaneka Corporation, Koninklijke DSM N.V., Lonza Group AG, Mitsubishi Corporation and Novozymes A/S.
|Base Year of the Analysis||2020|
|Segment Coverage||Product, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Archer Daniels Midland Company, BASF SE, Cargill Inc., DuPont de Nemours Inc., Fujifilm Holdings Corporation, General Electric Company, Henkel AG & Co. KGaA, Kaneka Corporation, Koninklijke DSM N.V., Lonza Group AG, Mitsubishi Corporation and Novozymes A/S.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at